InsidersTradesSigma
Swedish Orphan Biovitrum AB (publ): management transactions · Finland · FIN-FSA
FI:swedish-orphan-biovitrum-ab-publ-e3c7bcSE0000872095FI·FIN-FSAMcap 150.8Bn€Healthcare
Browse the full insider trade history of Swedish Orphan Biovitrum AB (publ), a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Swedish Orphan Biovitrum AB (publ) has recorded 8 reports. Market capitalisation: €150.8bn. The latest transaction was filed on 25 March 2026 — Purchase. Among the most active insiders: Guido Oelkers. All data is openly available.
8
Insider Decl.
0
Thresholds
€6m
7 ops.
Buy Volume
€446,604
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
434.20 €
Analyst consensus
13 analystsBuy
308.00 €Target 456.77 €(+5%)530.00 €
Income statement
Revenue28.24 Bn€
Gross profit21.99 Bn€78% margin
Net income478.0 M€3.2% margin
Valuation
PER (trailing)167.0x
PER (forward)19.3x
P/Book3.7x
Beta0.26
Balance sheet & cash
Market cap150.78 Bn€
Total debt11.49 Bn€
Free Cash Flow5.41 Bn€
Debt / Equity47%
Profitability & ownership
ROE2.3%
ROA7.0%
% insiders10.1%
% institutions73.3%
Last declaration on 25 March 2026
Declarations8 total
Executives●Purchase18FIN-FSA
€53,4931,366 shares@ €39.160.0000% mcap100.0% of flow
Aktie
FI:A003X324-1·
Ideal exit: 18 Dec 2026 (T+270)
Executives●Purchase18FIN-FSA
€72,3831,900 shares@ €38.09650.0000% mcap100.0% of flow
Aktie
FI:A003V827-1·
Ideal exit: 7 Nov 2026 (T+270)
Executives●Purchase18FIN-FSA
P
Per Richard Torbjörn HallbergAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan€1m58,230 shares@ €19.04750.0007% mcap100.0% of flow
Aktie
FI:A003T242-1·
Ideal exit: 28 Jul 2026 (T+270)
Executives●Sale18FIN-FSA
€446,60415,000 shares@ €29.77360.0003% mcap100.0% of flow
Aktie
FI:A003T253-1·
Executives●Purchase36FIN-FSA
€2m80,000 shares@ €19.04750.0010% mcap41.3% of flow
Aktie
FI:A003T241-1·
Ideal exit: 28 Jul 2026 (T+270)
Executives●Purchase29FIN-FSA
€2m80,000 shares@ €19.03920.0010% mcap41.3% of flow
Aktie
FI:A003T155-1·
Ideal exit: 25 Jul 2026 (T+270)
Executives●Purchase18FIN-FSA
€916,91348,026 shares@ €19.0920.0006% mcap100.0% of flow
Aktie
FI:A003T126-1·
Ideal exit: 21 Jul 2026 (T+270)
Executives●Purchase27FIN-FSA
€640,57533,622 shares@ €19.05230.0004% mcap17.4% of flow
Aktie
FI:A003T122-1·
Ideal exit: 24 Jul 2026 (T+270)
8 of 8 declarations